Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro

Hereditary sensory neuropathy type 1 (HSN-1) is a peripheral neuropathy most frequently caused by mutations in the SPTLC1 or SPTLC2 genes, which code for two subunits of the enzyme serine palmitoyltransferase (SPT). SPT catalyzes the first step of de novo sphingolipid synthesis. Mutations in SPT res...

Full description

Bibliographic Details
Main Authors: Emma R. Wilson, Umaiyal Kugathasan, Andrey Y. Abramov, Alex J. Clark, David L.H. Bennett, Mary M. Reilly, Linda Greensmith, Bernadett Kalmar
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996118301463
id doaj-ca04a88aa9f2466d8a8efd2ed27538c5
record_format Article
spelling doaj-ca04a88aa9f2466d8a8efd2ed27538c52021-03-22T12:46:33ZengElsevierNeurobiology of Disease1095-953X2018-09-01117114Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitroEmma R. Wilson0Umaiyal Kugathasan1Andrey Y. Abramov2Alex J. Clark3David L.H. Bennett4Mary M. Reilly5Linda Greensmith6Bernadett Kalmar7Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UKSobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UKDepartment of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UKNeural Injury Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UKNeural Injury Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UKMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UKSobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UKSobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Corresponding author.Hereditary sensory neuropathy type 1 (HSN-1) is a peripheral neuropathy most frequently caused by mutations in the SPTLC1 or SPTLC2 genes, which code for two subunits of the enzyme serine palmitoyltransferase (SPT). SPT catalyzes the first step of de novo sphingolipid synthesis. Mutations in SPT result in a change in enzyme substrate specificity, which causes the production of atypical deoxysphinganine and deoxymethylsphinganine, rather than the normal enzyme product, sphinganine. Levels of these abnormal compounds are elevated in blood of HSN-1 patients and this is thought to cause the peripheral motor and sensory nerve damage that is characteristic of the disease, by a largely unresolved mechanism. In this study, we show that exogenous application of these deoxysphingoid bases causes dose- and time-dependent neurotoxicity in primary mammalian neurons, as determined by analysis of cell survival and neurite length. Acutely, deoxysphingoid base neurotoxicity manifests in abnormal Ca2+ handling by the endoplasmic reticulum (ER) and mitochondria as well as dysregulation of cell membrane store-operated Ca2+ channels. The changes in intracellular Ca2+ handling are accompanied by an early loss of mitochondrial membrane potential in deoxysphingoid base-treated motor and sensory neurons. Thus, these results suggest that exogenous deoxysphingoid base application causes neuronal mitochondrial dysfunction and Ca2+ handling deficits, which may play a critical role in the pathogenesis of HSN-1.http://www.sciencedirect.com/science/article/pii/S0969996118301463SphingolipidDeoxysphingolipidNeuronPeripheral neuropathyES-285Mitochondria
collection DOAJ
language English
format Article
sources DOAJ
author Emma R. Wilson
Umaiyal Kugathasan
Andrey Y. Abramov
Alex J. Clark
David L.H. Bennett
Mary M. Reilly
Linda Greensmith
Bernadett Kalmar
spellingShingle Emma R. Wilson
Umaiyal Kugathasan
Andrey Y. Abramov
Alex J. Clark
David L.H. Bennett
Mary M. Reilly
Linda Greensmith
Bernadett Kalmar
Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
Neurobiology of Disease
Sphingolipid
Deoxysphingolipid
Neuron
Peripheral neuropathy
ES-285
Mitochondria
author_facet Emma R. Wilson
Umaiyal Kugathasan
Andrey Y. Abramov
Alex J. Clark
David L.H. Bennett
Mary M. Reilly
Linda Greensmith
Bernadett Kalmar
author_sort Emma R. Wilson
title Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
title_short Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
title_full Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
title_fullStr Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
title_full_unstemmed Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
title_sort hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2018-09-01
description Hereditary sensory neuropathy type 1 (HSN-1) is a peripheral neuropathy most frequently caused by mutations in the SPTLC1 or SPTLC2 genes, which code for two subunits of the enzyme serine palmitoyltransferase (SPT). SPT catalyzes the first step of de novo sphingolipid synthesis. Mutations in SPT result in a change in enzyme substrate specificity, which causes the production of atypical deoxysphinganine and deoxymethylsphinganine, rather than the normal enzyme product, sphinganine. Levels of these abnormal compounds are elevated in blood of HSN-1 patients and this is thought to cause the peripheral motor and sensory nerve damage that is characteristic of the disease, by a largely unresolved mechanism. In this study, we show that exogenous application of these deoxysphingoid bases causes dose- and time-dependent neurotoxicity in primary mammalian neurons, as determined by analysis of cell survival and neurite length. Acutely, deoxysphingoid base neurotoxicity manifests in abnormal Ca2+ handling by the endoplasmic reticulum (ER) and mitochondria as well as dysregulation of cell membrane store-operated Ca2+ channels. The changes in intracellular Ca2+ handling are accompanied by an early loss of mitochondrial membrane potential in deoxysphingoid base-treated motor and sensory neurons. Thus, these results suggest that exogenous deoxysphingoid base application causes neuronal mitochondrial dysfunction and Ca2+ handling deficits, which may play a critical role in the pathogenesis of HSN-1.
topic Sphingolipid
Deoxysphingolipid
Neuron
Peripheral neuropathy
ES-285
Mitochondria
url http://www.sciencedirect.com/science/article/pii/S0969996118301463
work_keys_str_mv AT emmarwilson hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT umaiyalkugathasan hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT andreyyabramov hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT alexjclark hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT davidlhbennett hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT marymreilly hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT lindagreensmith hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
AT bernadettkalmar hereditarysensoryneuropathytype1associateddeoxysphingolipidscauseneurotoxicityacutecalciumhandlingabnormalitiesandmitochondrialdysfunctioninvitro
_version_ 1724207946033790976